{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:05:05Z","timestamp":1790856305085,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81801630"],"award-info":[{"award-number":["81801630"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Nature Science Foundation of Hebei Province","award":["H2018307047"],"award-info":[{"award-number":["H2018307047"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To further investigate the clinical characteristics and circulating lymphocyte profiles of patients with early-onset primary Sj\u00f6gren\u2019s syndrome (pSS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>Data of 333 patients with pSS were analysed retrospectively. Early onset was defined as a pSS diagnosis at an age of 35\u2009years or younger. The clinical, laboratory and immunophenotypic profiles of peripheral blood lymphocyte subsets were compared between early- and later-onset pSS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Thirty-six (10.81%) patients matched the definition of early-onset pSS, with age at disease onset being 28.97\u2009\u2009(5.53)\u2009years. Elevated serum IgG level (77.14% vs 31.16%, P &amp;lt;0.001), low C3 (41.67% vs 20.20%, P =0.004) and C4 levels (27.78% vs 6.40%, P &amp;lt;0.001), anti-SSA positivity (91.67% vs 51.85%, P &amp;lt;0.001) and anti-SSB positivity (50% vs 20.54%, P &amp;lt;0.001) were more frequent in early-onset patients. The frequencies of hematological (80.56% vs 52.53%, P =0.001), renal (19.44% vs 5.05%, P =0.005) and mucocutaneous involvement (50% vs 22.56%, P &amp;lt;0.001) were significantly higher in the early-onset pSS group, which showed a higher 2010 EULAR SS Disease Activity Index (ESSDAI) [11(6.25\u201317) vs 7(3\u201312); P =0.003], compared with the later-onset group. In addition, profound CD4+ T-cell lymphopenia was found in patients with early-onset.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with early-onset pSS have distinctive clinical manifestations and greater activation of the cellular immune system, present with more severe clinical symptoms and immunological features, have increased activation of circulating T cells and have an unfavourable prognosis. Thus, they require more positive treatment with glucocorticoids and\/or immunosuppressants and merit closer follow-up and regular monitoring.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab367","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T11:22:23Z","timestamp":1618658543000},"page":"597-605","source":"Crossref","is-referenced-by-count":22,"title":["Patients with early-onset primary Sj\u00f6gren\u2019s syndrome have distinctive clinical manifestations and circulating lymphocyte profiles"],"prefix":"10.1093","volume":"61","author":[{"given":"Lin","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhifei","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xiaoran","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Meilu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yixuan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Xiuying","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yashuang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Jingjing","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Shaoying","sequence":"additional","affiliation":[{"name":"Department of Graduate School, Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Graduate School, Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Lijun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Fengxiao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"2022020819082642300_keab367-B1","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2022020819082642300_keab367-B2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2022020819082642300_keab367-B3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Baldini","year":"2014","journal-title":"Rheumatology"},{"key":"2022020819082642300_keab367-B4","first-page":"247","article-title":"The epidemiology of Sjogren's syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2022020819082642300_keab367-B5","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/jcm9072299","article-title":"Current state of knowledge on primary Sjogren's syndrome, an autoimmune exocrinopathy","volume":"9","author":"Parisis","year":"2020","journal-title":"J Clin Med"},{"key":"2022020819082642300_keab367-B6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/CMAMD.S4935","article-title":"Pattern of Young and Old Onset Rheumatoid Arthritis (YORA and EORA) among a group of Egyptian patients with rheumatoid arthritis","volume":"3","author":"El-Labban","year":"2010","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"2022020819082642300_keab367-B7","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/0961203317696593","article-title":"Disease evolution in late-onset and early-onset systemic lupus erythematosus","volume":"26","author":"Aljohani","year":"2017","journal-title":"Lupus"},{"key":"2022020819082642300_keab367-B8","doi-asserted-by":"crossref","first-page":"594096","DOI":"10.3389\/fimmu.2020.594096","article-title":"Primary Sjogren's syndrome of early and late onset: distinct clinical phenotypes and lymphoma development","volume":"11","author":"Goules","year":"2020","journal-title":"Front Immunol"},{"key":"2022020819082642300_keab367-B9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/rheumatology\/key392","article-title":"Is early-onset primary Sjogren's syndrome a worse prognosis form of the disease?","volume":"58","author":"Anquetil","year":"2019","journal-title":"Rheumatology"},{"key":"2022020819082642300_keab367-B10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120398678920019","article-title":"Young onset of primary Sjogren's syndrome: clinical and immunological characteristics","volume":"7","author":"Ramos-Casals","year":"1998","journal-title":"Lupus"},{"key":"2022020819082642300_keab367-B11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbspin.2010.05.008","article-title":"Elderly onset of primary Sjogren's syndrome: clinical manifestations, serological features and oral\/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients","volume":"78","author":"Botsios","year":"2011","journal-title":"Joint Bone Spine"},{"key":"2022020819082642300_keab367-B12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","article-title":"Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)","volume":"74","author":"Seror","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022020819082642300_keab367-B13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022020819082642300_keab367-B14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","article-title":"Defining disease activity states and clinically meaningful improvement in primary Sj?gren's syndrome with EULAR primary Sj?gren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022020819082642300_keab367-B15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology"},{"key":"2022020819082642300_keab367-B16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sjogren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zeron","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022020819082642300_keab367-B17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.lab.2006.01.001","article-title":"Characterization of peripheral natural killer cells in primary Sjogren's syndrome: impaired NK cell activity and low NK cell number","volume":"147","author":"Izumi","year":"2006","journal-title":"J Lab Clin Med"},{"key":"2022020819082642300_keab367-B18","doi-asserted-by":"crossref","first-page":"7523914","DOI":"10.1155\/2020\/7523914","article-title":"The increased ratio of blood CD56bright NK to CD56dim NK is a distinguishing feature of primary Sj\u00f6gren\u2019s syndrome","volume":"2020","author":"Ming","year":"2020","journal-title":"J Immunol Res"},{"key":"2022020819082642300_keab367-B19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.20093","article-title":"Sjogren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren's syndrome","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2022020819082642300_keab367-B20","first-page":"102","article-title":"How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project)","volume":"36 Suppl 112","author":"Brito-Zeron","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2022020819082642300_keab367-B21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sjogren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med"},{"key":"2022020819082642300_keab367-B22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","article-title":"Clinical and immunological parameters of Sjogren's syndrome","volume":"17","author":"Psianou","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2022020819082642300_keab367-B23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/OARRR.S167783","article-title":"Sjogren's syndrome and systemic lupus erythematosus: links and risks","volume":"11","author":"Pasoto","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"2022020819082642300_keab367-B24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ng.2779","article-title":"A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23","volume":"45","author":"Li","year":"2013","journal-title":"Nat Genet"},{"key":"2022020819082642300_keab367-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/298506","article-title":"Association between secondary and primary Sjogren's syndrome in a large collection of lupus families","volume":"2015","author":"Aggarwal","year":"2015","journal-title":"Autoimmune Dis"},{"key":"2022020819082642300_keab367-B26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2017.10.004","article-title":"Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: role of methylating enzymes","volume":"88","author":"Mavragani","year":"2018","journal-title":"J Autoimmun"},{"key":"2022020819082642300_keab367-B27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/1756-185X.12088","article-title":"The clinical and laboratory characteristics of Sjogren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study","volume":"16","author":"Yang","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"2022020819082642300_keab367-B28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2022020819082642300_keab367-B29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2022020819082642300_keab367-B30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjogren's syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022020819082642300_keab367-B31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology"},{"key":"2022020819082642300_keab367-B32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary Sj\u00f6gren's syndrome","volume":"41","author":"Solans-Laqu\u00e9","year":"2011","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab367\/39773321\/keab367.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/2\/597\/42368713\/keab367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/2\/597\/42368713\/keab367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T19:10:17Z","timestamp":1644347417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/2\/597\/6241090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,20]]},"published-print":{"date-parts":[[2022,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab367","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,4,20]]}}}